Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus.
about
Comparison of Fluorinated and Nonfluorinated Lipids in Self-Adjuvanting Delivery Systems for Peptide-Based Vaccines.Novel platform technology for modular mucosal vaccine that protects against streptococcus.Intranasal delivery of nanoparticle-based vaccines.Current Demands for Food-Approved Liposome Nanoparticles in Food and Safety Sector.Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery.
P2860
Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Liposome-based intranasal deli ...... against group A streptococcus.
@en
type
label
Liposome-based intranasal deli ...... against group A streptococcus.
@en
prefLabel
Liposome-based intranasal deli ...... against group A streptococcus.
@en
P2093
P50
P1433
P1476
Liposome-based intranasal deli ...... against group A streptococcus.
@en
P2093
Ashwini Kumar Giddam
Khairunnisa Abdul Ghaffar
Michael R Batzloff
P304
P356
10.1016/J.ACTBIO.2016.04.012
P577
2016-04-07T00:00:00Z